These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 25534293)

  • 1. Differentially regulated miRNAs as prognostic biomarkers in the blood of primary CNS lymphoma patients.
    Roth P; Keller A; Hoheisel JD; Codo P; Bauer AS; Backes C; Leidinger P; Meese E; Thiel E; Korfel A; Weller M
    Eur J Cancer; 2015 Feb; 51(3):382-90. PubMed ID: 25534293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Downregulation of serum microRNA-205 as a potential diagnostic and prognostic biomarker for human glioma.
    Yue X; Lan F; Hu M; Pan Q; Wang Q; Wang J
    J Neurosurg; 2016 Jan; 124(1):122-8. PubMed ID: 26230475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-101, miR-548b, miR-554, and miR-1202 are reliable prognosis predictors of the miRNAs associated with cancer immunity in primary central nervous system lymphoma.
    Takashima Y; Kawaguchi A; Iwadate Y; Hondoh H; Fukai J; Kajiwara K; Hayano A; Yamanaka R
    PLoS One; 2020; 15(2):e0229577. PubMed ID: 32101576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA signature constituted of miR-30d, miR-93, and miR-181b is a promising prognostic marker in primary central nervous system lymphoma.
    Takashima Y; Kawaguchi A; Iwadate Y; Hondoh H; Fukai J; Kajiwara K; Hayano A; Yamanaka R
    PLoS One; 2019; 14(1):e0210400. PubMed ID: 30615673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic impact of intraocular involvement in primary CNS lymphoma: experience from the G-PCNSL-SG1 trial.
    Kreher S; Strehlow F; Martus P; Roth P; Hertenstein B; Röth A; Birnbaum T; Griesinger F; Rauch M; Kanz L; Thiel E; Weller M; Korfel A
    Ann Hematol; 2015 Mar; 94(3):409-14. PubMed ID: 25217230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TP53 hotspot mutations are predictive of survival in primary central nervous system lymphoma patients treated with combination chemotherapy.
    Munch-Petersen HD; Asmar F; Dimopoulos K; Areškevičiūtė A; Brown P; Girkov MS; Pedersen A; Sjö LD; Heegaard S; Broholm H; Kristensen LS; Ralfkiaer E; Grønbæk K
    Acta Neuropathol Commun; 2016 Apr; 4():40. PubMed ID: 27101868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential micro-RNA expression in primary CNS and nodal diffuse large B-cell lymphomas.
    Fischer L; Hummel M; Korfel A; Lenze D; Joehrens K; Thiel E
    Neuro Oncol; 2011 Oct; 13(10):1090-8. PubMed ID: 21803762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Cleveland Clinic experience with primary central nervous system lymphoma.
    Xie H; Ahluwalia MS; Peereboom DM
    Am J Clin Oncol; 2015 Apr; 38(2):140-6. PubMed ID: 23608829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BCL-6 expression predicts improved survival in patients with primary central nervous system lymphoma.
    Braaten KM; Betensky RA; de Leval L; Okada Y; Hochberg FH; Louis DN; Harris NL; Batchelor TT
    Clin Cancer Res; 2003 Mar; 9(3):1063-9. PubMed ID: 12631608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic impact of microRNA-145 down-regulation in adult T-cell leukemia/lymphoma.
    Xia H; Yamada S; Aoyama M; Sato F; Masaki A; Ge Y; Ri M; Ishida T; Ueda R; Utsunomiya A; Asai K; Inagaki H
    Hum Pathol; 2014 Jun; 45(6):1192-8. PubMed ID: 24745613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miRNA profiling identifies candidate mirnas for bladder cancer diagnosis and clinical outcome.
    Ratert N; Meyer HA; Jung M; Lioudmer P; Mollenkopf HJ; Wagner I; Miller K; Kilic E; Erbersdobler A; Weikert S; Jung K
    J Mol Diagn; 2013 Sep; 15(5):695-705. PubMed ID: 23945108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miRNA expression in breast cancer varies with lymph node metastasis and other clinicopathologic features.
    Wang B; Li J; Sun M; Sun L; Zhang X
    IUBMB Life; 2014 May; 66(5):371-7. PubMed ID: 24846313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-30c as a novel diagnostic biomarker for primary and secondary B-cell lymphoma of the CNS.
    Baraniskin A; Chomiak M; Ahle G; Gress T; Buchholz M; Turewicz M; Eisenacher M; Margold M; Schlegel U; Schmiegel W; Hahn S; Schroers R
    J Neurooncol; 2018 May; 137(3):463-468. PubMed ID: 29327175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of microRNAs in the cerebrospinal fluid as marker for primary diffuse large B-cell lymphoma of the central nervous system.
    Baraniskin A; Kuhnhenn J; Schlegel U; Chan A; Deckert M; Gold R; Maghnouj A; Zöllner H; Reinacher-Schick A; Schmiegel W; Hahn SA; Schroers R
    Blood; 2011 Mar; 117(11):3140-6. PubMed ID: 21200023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dysregulation of global microRNA expression in splenic marginal zone lymphoma and influence of chronic hepatitis C virus infection.
    Peveling-Oberhag J; Crisman G; Schmidt A; Döring C; Lucioni M; Arcaini L; Rattotti S; Hartmann S; Piiper A; Hofmann WP; Paulli M; Küppers R; Zeuzem S; Hansmann ML
    Leukemia; 2012 Jul; 26(7):1654-62. PubMed ID: 22307176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends in survival from primary central nervous system lymphoma, 1975-1999: a population-based analysis.
    Panageas KS; Elkin EB; DeAngelis LM; Ben-Porat L; Abrey LE
    Cancer; 2005 Dec; 104(11):2466-72. PubMed ID: 16240449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prognostic value of serum methotrexate area under curve in elderly primary CNS lymphoma patients.
    Kasenda B; Rehberg M; Thürmann P; Franzem M; Veelken H; Fritsch K; Schorb E; Finke J; Lebiedz D; Illerhaus G
    Ann Hematol; 2012 Aug; 91(8):1257-64. PubMed ID: 22456893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary central nervous system lymphoma: the Memorial Sloan-Kettering Cancer Center prognostic model.
    Abrey LE; Ben-Porat L; Panageas KS; Yahalom J; Berkey B; Curran W; Schultz C; Leibel S; Nelson D; Mehta M; DeAngelis LM
    J Clin Oncol; 2006 Dec; 24(36):5711-5. PubMed ID: 17116938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of Genomic Alteration in Primary Central Nervous System Lymphoma and the Expression of Some Related Genes.
    Zhou Y; Liu W; Xu Z; Zhu H; Xiao D; Su W; Zeng R; Feng Y; Duan Y; Zhou J; Zhong M
    Neoplasia; 2018 Oct; 20(10):1059-1069. PubMed ID: 30227305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum microRNA expression profiling predict response to R-CHOP treatment in diffuse large B cell lymphoma patients.
    Song G; Gu L; Li J; Tang Z; Liu H; Chen B; Sun X; He B; Pan Y; Wang S; Cho WC
    Ann Hematol; 2014 Oct; 93(10):1735-43. PubMed ID: 24858372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.